CarolineCriagBillingsleyMD
Obstetrics & Gynecology • Cincinnati, OHGynecologic Oncology
Assistant Professor
Dr. Billingsley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2139 Auburn Ave
Cincinnati, OH 45219Phone+1 513-585-2323Fax+1 513-585-4893
Education & Training
Ohio State University/Mt Carmel HospitalFellowship, Gynecologic Oncology, 2012 - 2015
Medical University of South CarolinaResidency, Obstetrics and Gynecology, 2008 - 2012- Medical University of South CarolinaClass of 2008
Certifications & Licensure
KY State Medical License 2015 - 2025
OH State Medical License 2012 - 2025
SC State Medical License 2010 - 2012- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Publications & Presentations
PubMed
- 22 citationsDoes intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?Floor J. Backes, Caroline C. Billingsley, Douglas Martin, Brent J. Tierney, Eric L. Eisenhauer
Gynecologic Oncology. 2014-10-01 - 140 citationsCombined microsatellite instability, MLH1 methylation analysis, and immunohistochemistry for Lynch syndrome screening in endometrial cancers from GOG210: An NRG Oncolo...Paul J. Goodfellow, Caroline C. Billingsley, Heather A. Lankes, Shamshad Ali, David E. Cohn
Journal of Clinical Oncology. 2015-12-20 - 123 citationsPolymerase ɛ (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing.Caroline C. Billingsley, David E. Cohn, David G. Mutch, Julie A. Stephens, Adrian A. Suarez
Cancer. 2015-02-01
Press Mentions
Approval of Elahere Expands Treatment Options for Some Advanced Ovarian CancersApril 25th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
